(Q33397929)

26 July 2017

title

A phase II trial of pemetrexed in combination with carboplatin in patients with recurrent ovarian or primary peritoneal cancer (English)

1 reference

26 July 2017

main subject

phase II clinical trial

0 references

1 reference

1

Jalid Sehouli

0 references

Cezary Szczylik

5

object named as

Cezary Szczylik

1 reference

26 July 2017

Ana Maria Alvarez

2

1 reference

26 July 2017

Shokoufeh Manouchehrpour

3

1 reference

26 July 2017

Prafull Ghatage

4

1 reference

26 July 2017

Annamaria Zimmermann

6

1 reference

26 July 2017

Thomas Bauknecht

7

1 reference

26 July 2017

Katherine Y Look

8

1 reference

26 July 2017

Gultan Oskay-Öezcelik

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

26 July 2017

1 reference

26 July 2017

volume

124

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

205-209

1 reference

Focus on epithelial ovarian cancer

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Management of platinum-sensitive recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Pemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

A phase-I trial of pemetrexed plus carboplatin in recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.09.007

10.1016/J.YGYNO.2011.09.007

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference